Microvascular Endothelial Cells (MVEC and MVECPRO2™)

Placental microvascular endothelial cells are fetal in origin and with the cytotrophoblasts form the maternal-fetal barrier.

Available in standard and PRO2 (low oxygen) formats
Verified competent for tube formation
Immunopositive for CD31, CD29, & VE-Cadherin
Can be expanded in vitro when cultured as directed

PRICE:

$1,350.00 – $1,500.00

overview

The Amnion Foundation’s human placental microvascular endothelial cells (MVEC) are isolated from full-term placenta. These cells are fetal in origin and form the capillary network within the chorionic villi. Together with the placental trophoblasts, these cells comprise the maternal-fetal barrier and influence proper development of the placenta through autocrine and paracrine signaling. MVEC are established and grown from each donor in both standard culture conditions (MVEC) and under conditions of low oxygen, or physiologically relevant oxygen (MVECPRO2™). The MVEC available from the Amnion Foundation are immunopositive for CD31, CD29, and VE-cadherin and confirmed to be competent for tube formation. We also offer donor-matched cytotrophoblasts and MVEC to support your projects and are available to collaborate with you to meet your research needs.

details

Derived from human term placenta after a healthy birth and are fetal in origin
500K cells / vial post-thaw
Product Code #
- AF1240 – Price: $1,350.00
- AF1245 – Price: $1,500.00
Single donor origin (non-pooled)
Multiple Lots available from independent donors
Passage Levels: P-4 to P-5
Phenotypically characterized by flow cytometry (CD31+, CD29+, CD45-, CD34+, VE-cadherin+, VEGFR1+, CD146+, CD133+) and confirmed competent for tube formation
Post-thaw, MVEC can be utilized through at least P-6 to P-7
Confirmed non-reactive for HBsAg, HBCore, HIV-1/HIV-2 + O, HTLV I/II, HIV/HCV/HBV NAT, West Nile Virus NAT
Sterile; screened for endotoxin
This non-GMP product is for research use only and cannot be used in therapy or diagnostics.